Postmenopausal

Reproductive

19 drugs in development·13 companies·1 clinical trial

Drug Pipeline by Phase

Approved(9)

Drug	Company
afinitor	Novartis AG (NVS)
alendronate	Mylan II B.V. (MYL)
everolimus	Mylan II B.V. (MYL)
Forteo®	ELI LILLY & Co (LLY)
progesterone	DR REDDYS LABORATORIES LTD (RDY)
teriparatide	Amphastar Pharmaceuticals, Inc. (AMPH)
tykerb	Novartis AG (NVS)
tymlos	Radius Health, Inc. (RDUS)
xgeva	AMGEN INC (AMGN)

Phase 3(6)

Drug	Company
abaloparatide-td	Radius Health, Inc. (RDUS)
ENZ215	ENANTA PHARMACEUTICALS INC (ENTA)
ENZ215	Crinetics Pharmaceuticals, Inc. (CRNX)
jnp-0201	JUNIPER PHARMACEUTICALS INC (JNP)
Prolia	Crinetics Pharmaceuticals, Inc. (CRNX)
Prolia	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1(2)

Drug	Company
KSHN001034	Crinetics Pharmaceuticals, Inc. (CRNX)
kshn001126	Amneal Pharmaceuticals, Inc. (AMRX)

Unknown(2)

Drug	Company
Femoston™	ABBOTT LABORATORIES (ABT)
HLX14	Organon & Co. (OGN)

BioSniper tracks 19 drugs in development for Postmenopausal across 13 companies.

There are 1 clinical trial targeting Postmenopausal tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.